Evidence map›Paper›PMID 34932462›Full record

ArticleEmerging infectious diseases2022

Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France.

Sarah Dellière, Brune Joannard, Mazouz Benderdouche, Anselme Mingui, Maud Gits-Muselli, Samia Hamane, Alexandre Alanio, Antoine Petit, Germaine Gabison, Martine Bagot and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 5 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 5 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Deciphering the genomic landscape ofMicrobial genomics · 2026
    Article
  7. Dermatophytosis: An Update on Global Epidemiology.Journal of fungi (Basel, Switzerland) · 2026
    Review
  8. The Journal of clinical and aesthetic dermatology · 2026
    Article
  9. Article
  10. Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  11. Article
  12. Review
  13. National Belgian Study on Terbinafine Resistance inJournal of fungi (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Dermatophytoses Caused byJournal of fungi (Basel, Switzerland) · 2025
    Article
  16. Terbinafine Resistance inAntibiotics (Basel, Switzerland) · 2025
    Review
  17. Cutaneous Infections Caused byJournal of clinical medicine · 2025
    Review
  18. Emergence of terbinafine-resistantJournal of clinical microbiology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sarah Dellière
Brune Joannard
Mazouz Benderdouche
Anselme Mingui
Maud Gits-Muselli
Samia Hamane
Alexandre Alanio
Antoine Petit
Germaine Gabison
Martine Bagot
Stéphane Bretagne
Hôpital Saint-Louis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe 7 cases of extensive tinea corporis since 2018 in a hospital in Paris, France, after failure to cure with terbinafine. Molecular analysis indicated Trichophyton mentagrophytes internal transcribed spacer type VIII (T. indotineae). This strain, which has mutations in the squalene epoxidase gene, is spreading on the Indian subcontinent.

Indexed as

TineaTrichophytonAntifungal AgentsArthrodermataceaeDrug Resistance, FungalFranceHumansParisAntifungal Agentsantifungal drug resistanceantimicrobial resistanceFrancefungihuman-to-human transmissionskin infectionssqualene epoxidaseterbinafineTrichophyton indotineaeTrichophyton mentagrophytes complex

Identifiers

PMID34932462
PMCPMC8714205
OpenAlexW4200196559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.